Hydroxyzine: Clinical Overview
Indications
Hydroxyzine is FDA-approved for anxiety/tension, pruritus from allergic conditions, and as preoperative/postoperative sedation, with specific dosing varying by indication and age. 1
Primary Indications:
- Anxiety and tension associated with psychoneurosis and as adjunct in organic disease states 1
- Pruritus management in allergic conditions including chronic urticaria, atopic dermatitis, contact dermatoses, and histamine-mediated pruritus 1
- Sedation for premedication and following general anesthesia 1
Guideline-Supported Uses:
- Urticaria: Hydroxyzine 10-50 mg at night can be added to nonsedating antihistamines to help patients sleep, though it adds little additional effect on urticaria control if H1 receptors are already saturated 2
- Generalized pruritus of unknown origin (GPUO): Sedative antihistamines like hydroxyzine are recommended only short-term or in palliative settings 3
- NOT recommended for pruritus in elderly skin due to safety concerns 3
Dosing Regimens
Adults:
- Anxiety/tension: 50-100 mg four times daily 1
- Pruritus: 25 mg three to four times daily 1
- Preoperative sedation: 50-100 mg 1
- Urticaria (off-label nighttime use): 10-50 mg at bedtime 2
Children:
- Under 6 years: 50 mg daily in divided doses (for both anxiety and pruritus) 1
- Over 6 years: 50-100 mg daily in divided doses (for both anxiety and pruritus) 1
- Preoperative sedation: 0.6 mg/kg body weight 1
- Atopic dermatitis: 0.7 mg/kg three times daily is as effective as 1.4 mg/kg three times daily with significantly less sedation 4
Dosing Adjustments:
- Renal impairment: Halve the dose in moderate renal impairment (creatinine clearance 10-20 mL/min); avoid in severe renal impairment (creatinine clearance <10 mL/min) 2
- Hepatic impairment: Avoid in severe liver disease due to inappropriate sedating effects 2
Dosing Strategy to Minimize Side Effects:
Bedtime dosing of hydroxyzine 50 mg maintains antihistamine efficacy while mitigating daytime psychomotor impairment compared to divided doses. 5
Side Effects
Common Adverse Effects:
- Sedation/drowsiness: Most common, occurring in 28% of patients, typically appears during first week and progressively diminishes 6
- Dry mouth: Reported in 14% of patients 6
- Weight gain: 12% of patients 6
- Loss of concentration: 9% of patients 6
- Insomnia: 9% of patients 6
- Irritability 5
Serious Concerns:
- CNS depression: Can cause fatigue, sedation, impaired memory, concentration, and psychomotor function 7
- Driving impairment: Clinical studies and DUID investigations demonstrate hydroxyzine impairs driving performance, with observations including erratic driving, crashes, and difficulty with coordination 7
- QT prolongation risk: Contraindicated in patients with prolonged QT interval 1
Pharmacokinetics in Children:
- Peak serum concentration of 47.4 ng/mL occurs at 2 hours after 0.7 mg/kg oral dose 4
- Elimination half-life is 7.1 hours (increases with age) 4
- Pruritus suppression >85% from 2-12 hours post-dose 4
Contraindications
Absolute Contraindications:
- Known hypersensitivity to hydroxyzine, cetirizine, or levocetirizine 1
- Prolonged QT interval 1
- Early pregnancy: Hydroxyzine is specifically contraindicated in early pregnancy as it induced fetal abnormalities in animal studies at doses above human therapeutic range 2, 1
- Severe liver disease: Sedating effect is inappropriate 2
- Severe renal impairment (creatinine clearance <10 mL/min) 2
Relative Contraindications and Cautions:
- Pregnancy (all trimesters): Best to avoid, though chlorphenamine often chosen when antihistamine necessary due to long safety record 2
- Lactation: Avoidance or caution recommended 2
- Elderly patients with pruritus: Should not be prescribed sedative antihistamines due to safety concerns 3
- Concurrent medications: Use caution with other CNS depressants given additive effects 7
Clinical Context:
In DUID investigations, 74% of hydroxyzine-positive drivers also had antidepressants, 44% had opioids, and 38% had anticonvulsants, highlighting dangerous polypharmacy patterns. 7 Only seven single-substance cases were identified, emphasizing the importance of screening for drug combinations 7.
Efficacy Notes:
- Anxiety: Hydroxyzine 50 mg/day produces statistically and clinically significant anxiolytic effects starting in the first week, maintained through 4 weeks, without rebound anxiety or withdrawal symptoms upon abrupt discontinuation 6
- Insomnia: Mixed efficacy demonstrated for sleep onset, maintenance, and quality; may be considered short-term when previous therapy ineffective, not tolerated, or contraindicated 8